FDA OKs Medtronic automated insulin system for young kids

The FDA approves Medtronic’s (NYSE:MDT) MiniMed 770G System, a hybrid closed-loop diabetes management device, for children ages 2 – 6 with type 1 diabetes, the first such system available in the U.S. for this population of children.

The system, a bluetooth-enabled version of the MiniMed 670G, measures blood sugar levels every five minutes and automatically adjusts insulin delivery.

At mealtime, users must manually request insulin doses to counter carbohydrate consumption.

https://seekingalpha.com/news/3610251-fda-oks-medtronic-automated-insulin-delivery-and-monitoring-system-for-young-kids